Valuation (79%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -10.16 | 15.08 |
PEG Ratio (TTM) | 0.05 | -0.59 |
P/S Ratio (TTM) | 0.36 | 0.84 |
P/B Ratio (TTM) | 0.58 | 1.32 |
P/FCF Ratio (TTM) | 5.92 | 5.73 |
Price to 5YR AVG Earnings Ratio | 4.57 | 7.73 |
Price to 5YR AVG FCF Ratio | 4.77 | 8.38 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | -2.89% | 5.86% |
ROE (TTM) | -5.50% | 8.84% |
Net Profit Margin (TTM) | -3.54% | 5.83% |
ROIC 5YR AVG | 23.24% | 20.88% |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -94.84% | 121.39% | 50.38% |
Revenue | 4.90% | 19.63% | 15.37% |
Net Income | -93.55% | 122.26% | 50.25% |
Cash Flow | 468.22% | 17.88% | 11.27% |
Health (67%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.74 | 2.47 |
Quick Ratio (TTM) | 1.57 | 1.42 |
D/E Ratio (TTM) | 0.17 | 0.36 |
Interest Coverage (TTM) | 10.89 | 29.67 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 2.56 | 3.68 |
LTL to 5YR AVG FCF | 0.83 | 2.67 |
Shares Outstanding Growth 5YR AVG | N/A | -2.91% |